CLHO Stock Overview
Operates hospitals in Egypt. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 6/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Cleopatra Hospitals Group S.A.E. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ج.م8.06 |
| 52 Week High | ج.م9.44 |
| 52 Week Low | ج.م4.30 |
| Beta | 0.47 |
| 11 Month Change | -5.18% |
| 3 Month Change | 22.31% |
| 1 Year Change | 75.22% |
| 33 Year Change | 70.40% |
| 5 Year Change | 34.33% |
| Change since IPO | -16.56% |
Recent News & Updates
Recent updates
Shareholder Returns
| CLHO | EG Healthcare | EG Market | |
|---|---|---|---|
| 7D | -1.8% | -2.9% | -1.1% |
| 1Y | 75.2% | 74.4% | 26.3% |
Return vs Industry: CLHO matched the EG Healthcare industry which returned 75.7% over the past year.
Return vs Market: CLHO exceeded the EG Market which returned 25.6% over the past year.
Price Volatility
| CLHO volatility | |
|---|---|
| CLHO Average Weekly Movement | 6.4% |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in EG Market | 9.5% |
| 10% least volatile stocks in EG Market | 3.8% |
Stable Share Price: CLHO has not had significant price volatility in the past 3 months compared to the EG market.
Volatility Over Time: CLHO's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | n/a | Ahmed Ezz Eldin Abdelaal | www.cleopatrahospitals.com |
Cleopatra Hospitals Group S.A.E. operates hospitals in Egypt. Its hospitals provide various medical services, including surgeries, admission, medical supervision, analyses, investigations, x-rays, and outpatient services. The company also operates six hospitals and two polyclinics, as well as an inpatient and outpatient pharmacies.
Cleopatra Hospitals Group S.A.E. Fundamentals Summary
| CLHO fundamental statistics | |
|---|---|
| Market cap | ج.م11.65b |
| Earnings (TTM) | ج.م453.53m |
| Revenue (TTM) | ج.م4.38b |
25.7x
P/E Ratio2.7x
P/S RatioIs CLHO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CLHO income statement (TTM) | |
|---|---|
| Revenue | ج.م4.38b |
| Cost of Revenue | ج.م2.83b |
| Gross Profit | ج.م1.55b |
| Other Expenses | ج.م1.10b |
| Earnings | ج.م453.53m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.31 |
| Gross Margin | 35.38% |
| Net Profit Margin | 10.35% |
| Debt/Equity Ratio | 54.5% |
How did CLHO perform over the long term?
See historical performance and comparison